Cargando…

The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study

BACKGROUND: Diabetes mellitus is a chronic disease which many factors are involved and is developing considerably worldwide. Increasing aging population and obesity in the societies has improved the scale of the type 2 diabetes significantly. The aim of this study was to determine the direct medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Davari, Majid, Boroumand, Zahra, Amini, Masoud, Aslani, Abolfazl, Hosseini, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872475/
https://www.ncbi.nlm.nih.gov/pubmed/27217937
http://dx.doi.org/10.4103/2008-7802.181758
_version_ 1782432735355207680
author Davari, Majid
Boroumand, Zahra
Amini, Masoud
Aslani, Abolfazl
Hosseini, Mohsen
author_facet Davari, Majid
Boroumand, Zahra
Amini, Masoud
Aslani, Abolfazl
Hosseini, Mohsen
author_sort Davari, Majid
collection PubMed
description BACKGROUND: Diabetes mellitus is a chronic disease which many factors are involved and is developing considerably worldwide. Increasing aging population and obesity in the societies has improved the scale of the type 2 diabetes significantly. The aim of this study was to determine the direct medical costs of outpatient cares of diabetes in Iran. METHODS: Active patients of Isfahan Endocrinology and Metabolism Research Center (IEMRC) by the end of March 2011 were employed for data extraction. Type 2 diabetics were classified into 4 groups based on their therapeutic regimens. Type and frequency of health care services were extracted from the patients’ profiles manually. The incidence of major diabetes complications were also examined from the subjects’ profiles. The numbers of services used by the patients in different treatment groups were multiplied by the desired medical tariffs to calculate the direct medical costs. RESULTS: 2898 number of cases was reviewed in this study; 63.8 % women and 36.2% men. 4.3% of the patients were placed group I; 50.1% in group II, and 34.6% and 11% in groups III and IV respectively. The age distribution of the patients varied widely from 30 to 90 years; 5.8% between 30 and 39 years, 62.3% between 40 and 59, and 31.9% at 60 and over. Nephropathy (72.4%), and neuropathy (39%) were the most frequent adverse effect between the type 2 diabetics in Isfahan. The group III with spending $192.3 in total was absorbed the highest amount of the resources between the patients’ groups. The average direct medical cost of outpatient cares of diabetics per year was 155.8 US $. CONCLUSIONS: The direct medical cost of diabetes management is progressed sharply in past years in Iran. Pharmaceutical expenditures was the main cost component of outpatient cares for diabetes. It is estimated that the Iranians directly spend approximately $4.05 milliard annually to manage 5.2 million diabetics in the country.
format Online
Article
Text
id pubmed-4872475
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-48724752016-05-23 The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study Davari, Majid Boroumand, Zahra Amini, Masoud Aslani, Abolfazl Hosseini, Mohsen Int J Prev Med Original Article BACKGROUND: Diabetes mellitus is a chronic disease which many factors are involved and is developing considerably worldwide. Increasing aging population and obesity in the societies has improved the scale of the type 2 diabetes significantly. The aim of this study was to determine the direct medical costs of outpatient cares of diabetes in Iran. METHODS: Active patients of Isfahan Endocrinology and Metabolism Research Center (IEMRC) by the end of March 2011 were employed for data extraction. Type 2 diabetics were classified into 4 groups based on their therapeutic regimens. Type and frequency of health care services were extracted from the patients’ profiles manually. The incidence of major diabetes complications were also examined from the subjects’ profiles. The numbers of services used by the patients in different treatment groups were multiplied by the desired medical tariffs to calculate the direct medical costs. RESULTS: 2898 number of cases was reviewed in this study; 63.8 % women and 36.2% men. 4.3% of the patients were placed group I; 50.1% in group II, and 34.6% and 11% in groups III and IV respectively. The age distribution of the patients varied widely from 30 to 90 years; 5.8% between 30 and 39 years, 62.3% between 40 and 59, and 31.9% at 60 and over. Nephropathy (72.4%), and neuropathy (39%) were the most frequent adverse effect between the type 2 diabetics in Isfahan. The group III with spending $192.3 in total was absorbed the highest amount of the resources between the patients’ groups. The average direct medical cost of outpatient cares of diabetics per year was 155.8 US $. CONCLUSIONS: The direct medical cost of diabetes management is progressed sharply in past years in Iran. Pharmaceutical expenditures was the main cost component of outpatient cares for diabetes. It is estimated that the Iranians directly spend approximately $4.05 milliard annually to manage 5.2 million diabetics in the country. Medknow Publications & Media Pvt Ltd 2016-05-04 /pmc/articles/PMC4872475/ /pubmed/27217937 http://dx.doi.org/10.4103/2008-7802.181758 Text en Copyright: © 2016 Davari M. http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Original Article
Davari, Majid
Boroumand, Zahra
Amini, Masoud
Aslani, Abolfazl
Hosseini, Mohsen
The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study
title The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study
title_full The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study
title_fullStr The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study
title_full_unstemmed The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study
title_short The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study
title_sort direct medical costs of outpatient cares of type 2 diabetes in iran: a retrospective study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872475/
https://www.ncbi.nlm.nih.gov/pubmed/27217937
http://dx.doi.org/10.4103/2008-7802.181758
work_keys_str_mv AT davarimajid thedirectmedicalcostsofoutpatientcaresoftype2diabetesiniranaretrospectivestudy
AT boroumandzahra thedirectmedicalcostsofoutpatientcaresoftype2diabetesiniranaretrospectivestudy
AT aminimasoud thedirectmedicalcostsofoutpatientcaresoftype2diabetesiniranaretrospectivestudy
AT aslaniabolfazl thedirectmedicalcostsofoutpatientcaresoftype2diabetesiniranaretrospectivestudy
AT hosseinimohsen thedirectmedicalcostsofoutpatientcaresoftype2diabetesiniranaretrospectivestudy
AT davarimajid directmedicalcostsofoutpatientcaresoftype2diabetesiniranaretrospectivestudy
AT boroumandzahra directmedicalcostsofoutpatientcaresoftype2diabetesiniranaretrospectivestudy
AT aminimasoud directmedicalcostsofoutpatientcaresoftype2diabetesiniranaretrospectivestudy
AT aslaniabolfazl directmedicalcostsofoutpatientcaresoftype2diabetesiniranaretrospectivestudy
AT hosseinimohsen directmedicalcostsofoutpatientcaresoftype2diabetesiniranaretrospectivestudy